Boehringer drug for resistant HIV approved
Aids Reader 15(8): 379 391
2005
ISSN/ISBN: 1053-0894 PMID: 16110551 Document Number: 590630
Document emailed within 1 workday
Related Documents
Dorn, F J. 1984: College counseling center internships: Are APA-approved sites selecting candidates from non-APA-approved training programs? Professional Psychology: Research and Practice 15(2): 131-132Knoben, J.E.; Scott, G.R.; Tonelli, R.J. 1990: An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations American Journal of Hospital Pharmacy 47(12): 2696-2700
Nightingale, S.L. 1989: From the Food and Drug Administration. Interferon alfa approved for Kaposi's sarcoma JAMA 261(3): 350
Horsburgh, C.Robert. 2008: Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons: what does the future hold in store? Journal of Infectious Diseases 198(11): 1577-1578
Baroian, O.V.; Zueva, V.S.; Shaginian, I.A. 1972: Role of antibiotics used under various conditions of air semination with drug resistant Staphylococci in the formation of resistant microbial populations in the human organism Antibiotiki 17(7): 647-651
Huang, F. 2010: Discussion about traditional Chinese medicine pharmacokinetics study based on first botanical drug approved by FDA Zhongguo Zhong Yao Za Zhi 35(7): 932-935
McNicholas, C.; Maddipati, R.; Zhao, Q.; Swor, E.; Peipert, J.F. 2015: Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration Obstetrics and Gynecology 125(3): 599-604
Yuan, W.; Sui, C.G.; Ma, X.; Ma, J. 2018: A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM Zhonghua Zhong Liu Za Zhi 40(5): 330-334
Gao, R. 2014: Firehawk® sirolimus target-eluting coronary stent approved by China Food and Drug Administration European Heart Journal 35(38): 2623-2624
Rajan, S.; Vora, A. 2012: Drug-resistant tuberculosis--are we resistant to its cure? Journal of the Association of Physicians of India 60: 9-10
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Robinson, C.A.; Proelss, H.; Stabler, T.V. 1982: Laboratory evaluation of the Boehringer Mannheim "Diagnostic M" automated discrete analyzer Clinical Chemistry 28(1): 105-109
Warren, L.; Jardillier, J.C.; Ordentlich, P. 1991: Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells Cancer Research 51(8): 1996-2001
Purandare, B. 2015: Successful Management of Highly Drug-Resistant Tuberculosis with Individualized Drug Susceptibility Testing Journal of the Association of Physicians of India 63(7): 94-95
Toffoli, G.; Bevilacqua, C.; Franceschin, A.; Boiocchi, M. 1989: Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatment Journal of ChemoTherapy 1(4 Suppl): 1159-1161
Makamure, B.; Mhaka, J.; Makumbirofa, S.; Mutetwa, R.; Mupfumi, L.; Mason, P.; Metcalfe, J.Z. 2013: Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe Plos one 8(2): E55872
Paramasivan, C.N.; Venkataraman, P.; Herbert, D. 1997: Minimal inhibitory concentrations of sulbactam/ampicillin against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis Microbios 89: 360-361
Micheletti, V.Celina.Dezoti.; Moreira, Jé.da.Silva.; Ribeiro, M.Osório.; Kritski, A.Lineu.; Braga, Jé.Ueleres. 2014: Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 40(2): 155-163
Choi, J-Yeon.; Kim, E-Jin.; Park, Y.Keun.; Lee, J-Shil.; Kim, S.Soon. 2008: National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005 Journal of Acquired Immune Deficiency Syndromes 49(3): 237-242
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071